ケトコナゾール (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ケトコナゾール" in Japanese language version.

refsWebsite

Global rank Japanese rank

29nih.gov

4^th place

24^th place

19doi.org

2^nd place

6^th place

2tga.gov.au

3,984^th place

low place

2pmda.go.jp

6,690^th place

394^th place

1europa.eu

68^th place

425^th place

1sfda.gov.cn

low place

1wikipedia.org

low place

1wiley.com

222^nd place

498^th place

1psychosomaticmedicine.org

low place

1google.co.jp

934^th place

57^th place

1medscape.org

low place

1dvm360.com

low place

1fda.gov

447^th place

1,043^rd place

1skintherapyletter.com

low place

doi.org

A. F. Carvalho MD PhD1, J. L. Cavalcante MD2, M. S. Castelo MD MSc1, M. C. O. Lima MD PhD (October 2007). “Augmentation strategies for treatment-resistant depression: a literature review” (English). Journal of Clinical Pharmacy and Therapeutics 32 (5): 415–428. doi:10.1111/j.1365-2710.2007.00846.x 2012年5月21日閲覧。.
Loose, D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.”. JCI 71 (5): 1495–1499. doi:10.1172/JCI110903. PMC 437014. PMID 6304148 18 April 2015閲覧。.
Loli P, Berselli ME, Tagliaferri M (December 1986). “Use of ketoconazole in the treatment of Cushing's syndrome”. J. Clin. Endocrinol. Metab. 63 (6): 1365–71. doi:10.1210/jcem-63-6-1365. PMID 3023421.
Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A (March 1990). “Successful treatment with ketoconazole of Cushing's syndrome in pregnancy”. Postgrad Med J 66 (773): 221–3. doi:10.1136/pgmj.66.773.221. PMC 2429473. PMID 2362890.
Berwaerts J, Verhelst J, Mahler C, Abs R (June 1999). “Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature”. Gynecol. Endocrinol. 13 (3): 175–82. doi:10.3109/09513599909167552. PMID 10451809.
Kazy Z, Puhó E, Czeizel AE (March 2005). “Population-based case-control study of oral ketoconazole treatment for birth outcomes”. Congenit Anom (Kyoto) 45 (1): 5–8. doi:10.1111/j.1741-4520.2005.00053.x. PMID 15737124.
Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes”. J. Clin. Invest. 71 (5): 1495–9. doi:10.1172/JCI110903. PMC 437014. PMID 6304148.
Witjes FJ, Debruyne FM, Fernandez del Moral P, Geboers AD (May 1989). “Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group”. Urology 33 (5): 411–5. doi:10.1016/0090-4295(89)90037-X. PMID 2652864.
De Coster R, Wouters W, Bruynseels J (January 1996). “P450-dependent enzymes as targets for prostate cancer therapy”. J. Steroid Biochem. Mol. Biol. 56 (1–6 Spec No): 133–43. doi:10.1016/0960-0760(95)00230-8. PMID 8603034.
Eil C (August 1992). “Ketoconazole binds to the human androgen receptor”. Horm. Metab. Res. 24 (8): 367–70. doi:10.1055/s-2007-1003337. PMID 1526623.
“Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells”. J. Clin. Invest. 72 (1): 404–8. (1983). doi:10.1172/jci110982. PMC 1129197. PMID 6135709.
“Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor”. Mol. Pharmacol. 70 (1): 329–39. (2006). doi:10.1124/mol.105.022046. PMID 16608920.
Chin TW, Loeb M, Fong IW (August 1995). “Effects of an acidic beverage (Glass of Orange Juice) on absorption of ketoconazole”. Antimicrobial Agents and Chemotherapy 39 (8): 1671–5. doi:10.1128/AAC.39.8.1671. PMC 162805. PMID 7486898.
Cartledge, JD; Midgley, J; Gazzard, BG (1997). “Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.”. AIDS 11 (15): 1839–44. doi:10.1097/00002030-199715000-00008. PMID 9412702 August 27, 2015閲覧。.
Sanglard, D; Ischer, F; Monod, M; Bille, J (1997). “Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.”. Microbiology 143 (Pt 2): 405–16. doi:10.1099/00221287-143-2-405. PMID 9043118 August 27, 2015閲覧。.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE (1998). “Ketoconazole shampoo: effect of long-term use in androgenic alopecia”. Dermatology (Basel) 196 (4): 474–7. doi:10.1159/000017954. PMID 9669136.
Piérard-Franchimont C, Goffin V, Henry F, Uhoda I, Braham C, Piérard GE (October 2002). “Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations”. Int J Cosmet Sci 24 (5): 249–56. doi:10.1046/j.1467-2494.2002.00145.x. PMID 18498517.
Khandpur S, Suman M, Reddy BS (August 2002). “Comparative efficacy of various treatment regimens for androgenetic alopecia in men”. J. Dermatol. 29 (8): 489–98. doi:10.1111/j.1346-8138.2002.tb00314.x. PMID 12227482.
Heeres J, Backx LJ, Mostmans JH, Van Cutsem J (August 1979). “Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent”. J. Med. Chem. 22 (8): 1003–5. doi:10.1021/jm00194a023. PMID 490531.

dvm360.com

veterinarymedicine.dvm360.com

KuKanich B (January 2008). “A review of selected systemic antifungal drugs for use in dogs and cats”. Veterinary Medicine.

europa.eu

ema.europa.eu

“European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole”. Press Release. European Medicines Agency (2013年7月26日). 2016年5月4日閲覧。

fda.gov

“FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems”. FDA Drug Safety Communication (U.S. Food and Drug Administration). (July 26, 2013) November 23, 2013閲覧。

google.co.jp

books.google.co.jp

Kenneth L. Becker (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 1197–. ISBN 978-0-7817-1750-2

medscape.org

“MedScape”. Ectopic Cortisol Production Derived From Malignant Testicular Masses: Treatment and Management. Nature Publishing Group. 18 April 2015閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Wolkowitz, OM; Reus VI (September 1999). “Treatment of depression with antiglucocorticoid drugs”. Psychosomatic Medicine 61 (5): 698–711. PMID 10511017.
Loose, D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.”. JCI 71 (5): 1495–1499. doi:10.1172/JCI110903. PMC 437014. PMID 6304148 18 April 2015閲覧。.
Loli P, Berselli ME, Tagliaferri M (December 1986). “Use of ketoconazole in the treatment of Cushing's syndrome”. J. Clin. Endocrinol. Metab. 63 (6): 1365–71. doi:10.1210/jcem-63-6-1365. PMID 3023421.
Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A (March 1990). “Successful treatment with ketoconazole of Cushing's syndrome in pregnancy”. Postgrad Med J 66 (773): 221–3. doi:10.1136/pgmj.66.773.221. PMC 2429473. PMID 2362890.
Berwaerts J, Verhelst J, Mahler C, Abs R (June 1999). “Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature”. Gynecol. Endocrinol. 13 (3): 175–82. doi:10.3109/09513599909167552. PMID 10451809.
Kazy Z, Puhó E, Czeizel AE (March 2005). “Population-based case-control study of oral ketoconazole treatment for birth outcomes”. Congenit Anom (Kyoto) 45 (1): 5–8. doi:10.1111/j.1741-4520.2005.00053.x. PMID 15737124.
Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes”. J. Clin. Invest. 71 (5): 1495–9. doi:10.1172/JCI110903. PMC 437014. PMID 6304148.
Witjes FJ, Debruyne FM, Fernandez del Moral P, Geboers AD (May 1989). “Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative Group”. Urology 33 (5): 411–5. doi:10.1016/0090-4295(89)90037-X. PMID 2652864.
De Coster R, Wouters W, Bruynseels J (January 1996). “P450-dependent enzymes as targets for prostate cancer therapy”. J. Steroid Biochem. Mol. Biol. 56 (1–6 Spec No): 133–43. doi:10.1016/0960-0760(95)00230-8. PMID 8603034.
Eil C (August 1992). “Ketoconazole binds to the human androgen receptor”. Horm. Metab. Res. 24 (8): 367–70. doi:10.1055/s-2007-1003337. PMID 1526623.
“Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells”. J. Clin. Invest. 72 (1): 404–8. (1983). doi:10.1172/jci110982. PMC 1129197. PMID 6135709.
“Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor”. Mol. Pharmacol. 70 (1): 329–39. (2006). doi:10.1124/mol.105.022046. PMID 16608920.
Chin TW, Loeb M, Fong IW (August 1995). “Effects of an acidic beverage (Glass of Orange Juice) on absorption of ketoconazole”. Antimicrobial Agents and Chemotherapy 39 (8): 1671–5. doi:10.1128/AAC.39.8.1671. PMC 162805. PMID 7486898.
Ghannoum MA, Rice LB (1999). “Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.”. Clin Microbiol Rev 12 (4): 501-17. PMC 88922. PMID 10515900.
Cartledge, JD; Midgley, J; Gazzard, BG (1997). “Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.”. AIDS 11 (15): 1839–44. doi:10.1097/00002030-199715000-00008. PMID 9412702 August 27, 2015閲覧。.
Sanglard, D; Ischer, F; Monod, M; Bille, J (1997). “Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.”. Microbiology 143 (Pt 2): 405–16. doi:10.1099/00221287-143-2-405. PMID 9043118 August 27, 2015閲覧。.
McElwee KJ, Shapiro JS (June 2012). “Promising therapies for treating and/or preventing androgenic alopecia”. Skin Therapy Lett. 17 (6): 1–4. PMID 22735503.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE (1998). “Ketoconazole shampoo: effect of long-term use in androgenic alopecia”. Dermatology (Basel) 196 (4): 474–7. doi:10.1159/000017954. PMID 9669136.
Piérard-Franchimont C, Goffin V, Henry F, Uhoda I, Braham C, Piérard GE (October 2002). “Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations”. Int J Cosmet Sci 24 (5): 249–56. doi:10.1046/j.1467-2494.2002.00145.x. PMID 18498517.
Khandpur S, Suman M, Reddy BS (August 2002). “Comparative efficacy of various treatment regimens for androgenetic alopecia in men”. J. Dermatol. 29 (8): 489–98. doi:10.1111/j.1346-8138.2002.tb00314.x. PMID 12227482.
Heeres J, Backx LJ, Mostmans JH, Van Cutsem J (August 1979). “Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent”. J. Med. Chem. 22 (8): 1003–5. doi:10.1021/jm00194a023. PMID 490531.

ncbi.nlm.nih.gov

Loose, D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.”. JCI 71 (5): 1495–1499. doi:10.1172/JCI110903. PMC 437014. PMID 6304148 18 April 2015閲覧。.
Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J, Alvarez A (March 1990). “Successful treatment with ketoconazole of Cushing's syndrome in pregnancy”. Postgrad Med J 66 (773): 221–3. doi:10.1136/pgmj.66.773.221. PMC 2429473. PMID 2362890.
Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D (May 1983). “Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes”. J. Clin. Invest. 71 (5): 1495–9. doi:10.1172/JCI110903. PMC 437014. PMID 6304148.
“Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells”. J. Clin. Invest. 72 (1): 404–8. (1983). doi:10.1172/jci110982. PMC 1129197. PMID 6135709.
Chin TW, Loeb M, Fong IW (August 1995). “Effects of an acidic beverage (Glass of Orange Juice) on absorption of ketoconazole”. Antimicrobial Agents and Chemotherapy 39 (8): 1671–5. doi:10.1128/AAC.39.8.1671. PMC 162805. PMID 7486898.
Ghannoum MA, Rice LB (1999). “Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.”. Clin Microbiol Rev 12 (4): 501-17. PMC 88922. PMID 10515900.
Cartledge, JD; Midgley, J; Gazzard, BG (1997). “Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.”. AIDS 11 (15): 1839–44. doi:10.1097/00002030-199715000-00008. PMID 9412702 August 27, 2015閲覧。.
Sanglard, D; Ischer, F; Monod, M; Bille, J (1997). “Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.”. Microbiology 143 (Pt 2): 405–16. doi:10.1099/00221287-143-2-405. PMID 9043118 August 27, 2015閲覧。.

pmda.go.jp

info.pmda.go.jp

“ニゾラールクリーム2% 添付文書” (2010年8月). 2016年5月4日閲覧。
“ニゾラールローション2% 添付文書” (2010年8月). 2016年5月4日閲覧。

psychosomaticmedicine.org

Wolkowitz, OM; Reus VI (September 1999). “Treatment of depression with antiglucocorticoid drugs”. Psychosomatic Medicine 61 (5): 698–711. PMID 10511017.

sfda.gov.cn

“国家食品药品监督管理总局关于停止生产销售使用酮康唑口服制剂的公告（2015年第85号）” (中国語). China Food and Drug Administration（英語版） (2015年6月25日). 2015年7月2日閲覧。

skintherapyletter.com

McElwee KJ, Shapiro JS (June 2012). “Promising therapies for treating and/or preventing androgenic alopecia”. Skin Therapy Lett. 17 (6): 1–4. PMID 22735503.

tga.gov.au

wikipedia.org

en.wikipedia.org

“国家食品药品监督管理总局关于停止生产销售使用酮康唑口服制剂的公告（2015年第85号）” (中国語). China Food and Drug Administration（英語版） (2015年6月25日). 2015年7月2日閲覧。

wiley.com

onlinelibrary.wiley.com

A. F. Carvalho MD PhD1, J. L. Cavalcante MD2, M. S. Castelo MD MSc1, M. C. O. Lima MD PhD (October 2007). “Augmentation strategies for treatment-resistant depression: a literature review” (English). Journal of Clinical Pharmacy and Therapeutics 32 (5): 415–428. doi:10.1111/j.1365-2710.2007.00846.x 2012年5月21日閲覧。.